


Healthcare Industry NewsFeed
HSMN NewsFeed - 17 May 2016
MiMedx Files Lawsuit Against Osiris For False And Misleading Representations
MiMedx Files Lawsuit Against Osiris For False And Misleading Representations
HSMN NewsFeed - 17 May 2016
Catalyst Pharmaceuticals Announces Reduction in Workforce as Part of Operating Expense Management Plan
Catalyst Pharmaceuticals Announces Reduction in Workforce as Part of Operating Expense Management Plan
HSMN NewsFeed - 17 May 2016
Leeds St James Acquires Eight Elekta Linear Accelerators for Advanced Cancer Treatment
Leeds St James Acquires Eight Elekta Linear Accelerators for Advanced Cancer Treatment
HSMN NewsFeed - 16 May 2016
Orthofix Announces 510(k) Clearance and US Limited Market Launch of FORZA PTC Interbody Spacer System
Orthofix Announces 510(k) Clearance and US Limited Market Launch of FORZA PTC Interbody Spacer System
HSMN NewsFeed - 16 May 2016
Allergan Announces Positive Pivotal Trial Results for Oculeve Intranasal Tear Neurostimulator
Allergan Announces Positive Pivotal Trial Results for Oculeve Intranasal Tear Neurostimulator
HSMN NewsFeed - 16 May 2016
The Medicines Company Appoints Tony Kingsley as President and Chief Operating Officer
The Medicines Company Appoints Tony Kingsley as President and Chief Operating Officer
HSMN NewsFeed - 16 May 2016
Luminex Corporation Signs Definitive Agreement to Acquire Nanosphere, Inc.
Luminex Corporation Signs Definitive Agreement to Acquire Nanosphere, Inc.
HSMN NewsFeed - 13 May 2016
Alprolix(R) (rFIXFc) approved in the EU for the treatment of haemophilia B
Alprolix(R) (rFIXFc) approved in the EU for the treatment of haemophilia B
HSMN NewsFeed - 12 May 2016
Cardiome Announces the Launch of ESMOCARD Solution for Injection in France
Cardiome Announces the Launch of ESMOCARD Solution for Injection in France
HSMN NewsFeed - 12 May 2016
Accera Completes Enrollment of Phase 3 NOURISH AD Study of AC-1204 for the Treatment of Alzheimer's Disease
Accera Completes Enrollment of Phase 3 NOURISH AD Study of AC-1204 for the Treatment of Alzheimer's Disease
HSMN NewsFeed - 12 May 2016
FDA Clears Next-Generation Version of EndoGastric Solutions’ EsophyX(R) Device
FDA Clears Next-Generation Version of EndoGastric Solutions’ EsophyX(R) Device
HSMN NewsFeed - 12 May 2016
Corvia Medical Announces CE Mark Approval And Enrollment Of First Patients In Randomized Clinical Study
Corvia Medical Announces CE Mark Approval And Enrollment Of First Patients In Randomized Clinical Study
HSMN NewsFeed - 11 May 2016
Isaac J. Bright, MD, Joins Synthetic Biologics as Vice President, Corporate Development
Isaac J. Bright, MD, Joins Synthetic Biologics as Vice President, Corporate Development
HSMN NewsFeed - 10 May 2016
Praveen Tyle, Ph.D. Joins Lexicon As Executive Vice President Of Research And Development
Praveen Tyle, Ph.D. Joins Lexicon As Executive Vice President Of Research And Development
HSMN NewsFeed - 10 May 2016
Aptinyx Raises $65 Million in Series A Financing to Advance Therapies for Neurological Disorders
Aptinyx Raises $65 Million in Series A Financing to Advance Therapies for Neurological Disorders
HSMN NewsFeed - 9 May 2016
Theravance Biopharma Announces FDA Approval of Expanded Label for VIBATIV(R) (telavancin)
Theravance Biopharma Announces FDA Approval of Expanded Label for VIBATIV(R) (telavancin)
HSMN NewsFeed - 9 May 2016
Personal Genome Diagnostics Names Industry Veteran Douglas Ward as Chief Executive Officer
Personal Genome Diagnostics Names Industry Veteran Douglas Ward as Chief Executive Officer
HSMN NewsFeed - 9 May 2016
Synthetic Biologics Appoints Deb Mathews, PharmD, as Vice President, Medical Affairs
Synthetic Biologics Appoints Deb Mathews, PharmD, as Vice President, Medical Affairs
HSMN NewsFeed - 5 May 2016
TearScience(R) Introduces LipiScan(TM) for Rapid High Definition (HD) Meibomian Imaging
TearScience(R) Introduces LipiScan(TM) for Rapid High Definition (HD) Meibomian Imaging
HSMN NewsFeed - 5 May 2016
TearScience(R) Introduces LipiScan(TM) for Rapid High Definition (HD) Meibomian Imaging
TearScience(R) Introduces LipiScan(TM) for Rapid High Definition (HD) Meibomian Imaging
HSMN NewsFeed - 5 May 2016
Aclaris Therapeutics, Inc. Appoints Kevin Scott as Vice President of Sales
Aclaris Therapeutics, Inc. Appoints Kevin Scott as Vice President of Sales
HSMN NewsFeed - 5 May 2016
Valeant Pharmaceuticals Announces Collaboration Between Bausch & Lomb And IBM
Valeant Pharmaceuticals Announces Collaboration Between Bausch & Lomb And IBM
HSMN NewsFeed - 5 May 2016
aTyr Pharma Appoints Grove Matsuoka as Senior Vice President, Product Programs and Planning
aTyr Pharma Appoints Grove Matsuoka as Senior Vice President, Product Programs and Planning
HSMN NewsFeed - 5 May 2016
Bicycle Therapeutics Strengthens Product Development Capabilities with Key Leadership Appointments
Bicycle Therapeutics Strengthens Product Development Capabilities with Key Leadership Appointments
HSMN NewsFeed - 5 May 2016
Applied DNA Sciences Appoints Bob Miglani as Chief of Business Development
Applied DNA Sciences Appoints Bob Miglani as Chief of Business Development
